Uncategorized

Safety Strategy for Cephalon Pain Drugs Receives FDA Approval

According to a Cephalon news release, the FDA has approved a risk evaluation and mitigation strategy for Cephalon’s Fentora and Actiq drugs to manage breakthrough pain in opioid-tolerant patients with cancer.

Leigh Page

Friday, July 22nd, 2011

Click here to read the Becker’s ASC Review coverage on Cephalon Fentora and Actig drugs.

Next Up in Uncategorized

3-level ACDF outcomes with or without a posterior stabilization system: 5 notes

Three-level anterior cervical discectomy and fusion saw stronger outcomes when supplemented with a circumferential cervical fusion using an investigational posterior…

By: Carly Behm
Monday, January 5th, 2026
Orthopedic starting pay reaches $576K: AMN Healthcare

Orthopedic surgeons have the highest average starting salary of 20 top-recruited specialties, according to AMN Health’s 2025 “Review of Physician…

By: Carly Behm
Tuesday, August 5th, 2025
Hospital for Special Surgery adds Abridge for AI documentation

New York City-based Hospital for Special Surgery will use Abridge, an artificial intelligence company for orthopedic documentation, according to a…

By: Carly Behm
Friday, July 25th, 2025

Comments are closed.

Strategic readiness for aging populations: How 4 health systems are preparing

Next Up in Uncategorized

3-level ACDF outcomes with or without a posterior stabilization system: 5 notes

Orthopedic starting pay reaches $576K: AMN Healthcare

Hospital for Special Surgery adds Abridge for AI documentation

Join the spine leaders & surgeons who start their day with Becker's